Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-01-03

Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bone marrow transplantation for leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Graft Versus Host Disease, Leukemia | Phase 3 | Status: WITHDRAWN